News

Healthcare

Healthcare Sector 1Q19: Best and Worst

Healthcare Sector 1Q19: Best and Worst

David Trainer | Equities.com |

The Healthcare sector ranks seventh out of the 11 sectors as detailed in our 1Q19 Sector Ratings for ETFs and Mutual Funds report. It gets our Neutral rating.


​At its Lowest Moment, Is Teligent (TLGT) Actually Closer to an Inflection Point Than Ever?

Stephen L Kanaval | Equities.com |

Does Teligent have the R&D to turn things around?


​Robotic Surgeries May be an Important Aid in Combating the Opioid Crisis

Stephen L Kanaval | Equities.com |

Stereotaxis, Inc. STXS is one company that is increasing their footprint in this space.


S&P 500 Sector SPDRs Preview

Mark Putrino | Equities.com |

An analysis of the supply and demand dynamics that are occurring in the S&P 500 Economic Sectors


Government Shutdown Harms Our Safety, Health and the Innovation Economy

Edward Kim | Equities.com |

The growing impact of this shutdown affects far more than just federal workers.


Testing the $260 Level Again...But This Time It's Different...

Mark Putrino | Equities.com |

The SPYs are testing support at the $260s level from the lows of February through May, October, and again in the first week of December. There is an important difference this time however.​


Premier Biomedical Expands Distribution Network for CBD / Hemp Oil Pain Relievers

Edward Kim | Equities.com |

Keep an eye on the 2018 Farm Bill, which may get a vote in Congress next week.


Are the Chickens Coming Home to Roost?

Mark Putrino | Equities.com |

If we rally, once again I will look for resistance around $280. However, the more important level to watch is $260. This is where the recent lows were. There is support around this level because it is where the lows were earlier this year. If this level br


Why I Am Not Bullish in the Near-Term...

Mark Putrino | Equities.com |

Resistance levels in some S&P 500 Sector SPDRs - XLK XLV XLE XLF.


With a Stout Advisory Board Canbiola is Aiming to Bring CBD to Every Chiropractor and Doctor

Stephen L Kanaval | Equities.com |

Canbiola, Inc. is one company looking to prove that CBD can cause a paradigm shift in the medical community.